|
|
 |
These are news releases that are related to our Investor efforts. Releases are listed in chronological order and are archived by year. Sign-up to receive news as it is released using the email and RSS tools below.
-
Mar 13, 2007
A proprietary small molecule multi-target inhibitor, CUDC-101 is being developed to target EGFR and another clinically validated cancer
CAMBRIDGE, Mass.--(BUSINESS WIRE)--March 14, 2007--Curis, Inc. (NASDAQ:CRIS), a drug development company focused on novel targeted medicines primarily for cancer treatment, today announced that it...
-
Feb 14, 2007
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb. 14, 2007--Curis, Inc. (NASDAQ:CRIS), a drug development company focusing on signaling pathway drug technologies to create new medicines primarily for...
-
Feb 1, 2007
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb. 1, 2007--Curis, Inc. (NASDAQ: CRIS), a therapeutic drug development company focusing on cancer, neurological and dermatological disease indications, will...
-
Jan 31, 2007
Trial tests safety of systemic administration of a Hedgehog
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jan. 31, 2007--Curis, Inc. (NASDAQ: CRIS), a therapeutic drug development company focusing on cancer, neurological and dermatological disease indications,...
|
